HK1075619A1 - New uses for anti-malarial therapeutic agents - Google Patents

New uses for anti-malarial therapeutic agents

Info

Publication number
HK1075619A1
HK1075619A1 HK05107810A HK05107810A HK1075619A1 HK 1075619 A1 HK1075619 A1 HK 1075619A1 HK 05107810 A HK05107810 A HK 05107810A HK 05107810 A HK05107810 A HK 05107810A HK 1075619 A1 HK1075619 A1 HK 1075619A1
Authority
HK
Hong Kong
Prior art keywords
therapeutic agents
new uses
malarial therapeutic
malarial
new
Prior art date
Application number
HK05107810A
Other languages
English (en)
Inventor
Lauren Charous
Original Assignee
Apt Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apt Pharmaceuticals Inc filed Critical Apt Pharmaceuticals Inc
Publication of HK1075619A1 publication Critical patent/HK1075619A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
HK05107810A 2001-11-09 2005-09-06 New uses for anti-malarial therapeutic agents HK1075619A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34587201P 2001-11-09 2001-11-09
PCT/US2002/036309 WO2003039546A1 (en) 2001-11-09 2002-11-12 New uses for anti-malarial therapeutic agents

Publications (1)

Publication Number Publication Date
HK1075619A1 true HK1075619A1 (en) 2005-12-23

Family

ID=23356861

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05107810A HK1075619A1 (en) 2001-11-09 2005-09-06 New uses for anti-malarial therapeutic agents

Country Status (10)

Country Link
US (1) US20040167162A1 (zh)
EP (1) EP1450803A4 (zh)
JP (1) JP2005512998A (zh)
CN (1) CN1289086C (zh)
AU (1) AU2002363443B2 (zh)
CA (1) CA2466338C (zh)
HK (1) HK1075619A1 (zh)
IL (1) IL161821A0 (zh)
MX (1) MXPA04004393A (zh)
WO (1) WO2003039546A1 (zh)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7084157B2 (en) * 2002-05-17 2006-08-01 Rajeev Raut Ophthalmic pharmaceutical compositions and methods for treating ocular inflammation
WO2004085402A1 (en) * 2003-03-27 2004-10-07 Council Of Scientific And Industrial Research Ring-substituted 8-aminoqunoline derivates as antimalarial agents
US20070134596A1 (en) * 2005-12-08 2007-06-14 Adrian Lungu Photosensitive printing element having nanoparticles and method for preparing the printing element
CN101466380A (zh) * 2006-02-16 2009-06-24 麦克莱恩医院 治疗帕金森病的方法和组合物
KR101067443B1 (ko) * 2009-06-23 2011-09-27 여오영 하이드록시클로로퀸을 함유하는 치핵 치료를 위한 국소투여용 주사제 조성물
CN103027915A (zh) * 2011-09-29 2013-04-10 中国医学科学院基础医学研究所 氯喹治疗和氯丙嗪预防肺感染和损伤的用途
CN103705516B (zh) * 2013-12-11 2016-01-06 武汉威立得生物医药有限公司 氯喔星在制备治疗或预防流感病毒感染的药物中的应用
KR101828553B1 (ko) * 2016-04-15 2018-02-13 한국화학연구원 신규한 벤조싸이오펜 유도체, 이의 약학적으로 허용 가능한 염 또는 이의 광학 이성질체, 이의 제조방법 및 이를 유효성분으로 함유하는 바이러스성 질환의 예방 또는 치료용 약학적 조성물
ES2844927T3 (es) 2016-06-28 2021-07-23 Hopitaux Paris Assist Publique Derivados de primaquina para la utilización en la prevención y/o el tratamiento de trastornos asociados al virus herpes gamma
CN111658648A (zh) * 2020-02-03 2020-09-15 中国人民解放军军事科学院军事医学研究院 4-氨基喹啉类化合物在治疗冠状病毒感染方面的应用
US20210244705A1 (en) * 2020-02-07 2021-08-12 Centre For Digestive Diseases Therapeutic compositions, products of manufacture and methods for ameliorating or preventing coronavirus infection
CN114908062B (zh) * 2020-02-16 2023-10-20 北京化工大学 盐酸甲氟喹或甲氟喹在制备治疗冠状病毒感染性疾病的药物的用途
US11007187B1 (en) * 2020-03-25 2021-05-18 Therapeutica Borealis Oy Medicine for Covid-19 and treatment
WO2021191496A1 (en) * 2020-03-25 2021-09-30 Therapeutica Borealis Oy Medicine for covid-19 and treatment
US11638722B2 (en) 2020-03-25 2023-05-02 Therapeutica Borealis Oy C/O Avance Attorneys Ltd. Medicine for Covid-19 and treatment
US11278602B2 (en) 2020-03-25 2022-03-22 Therapeutica Borealis Oy Medicine for Covid-19 and treatment
WO2021204717A1 (en) * 2020-04-06 2021-10-14 Oxandia Ltd Aminoquinolines for treating coronavirus infections
EP3892275A1 (en) * 2020-04-08 2021-10-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Aerosolization of hcq or its metabolites for the treatment of lung infections
CA3176360A1 (en) * 2020-04-21 2021-10-28 Noam Cohen Quinine and its use to generate innate immune response
CA3180854A1 (en) * 2020-04-24 2021-10-28 Thomas Julius Borody Products of manufacture and methods for treating, ameliorating or preventing microbial infections
US20230165851A1 (en) * 2020-04-27 2023-06-01 Immunologik Gmbh 6'-methoxycinchonan-9-ols for the treatment of coronaviral infections
CN115515935A (zh) * 2020-04-30 2022-12-23 中美华世通生物医药科技(武汉)股份有限公司 冠状病毒感染的治疗或预防
AU2021339013A1 (en) * 2020-09-14 2023-04-06 Philip Morris Products S.A. Pharmaceutical composition comprising hydroxychloroquine and uses thereof
DE102021000717A1 (de) * 2021-02-12 2022-08-18 Forschungszentrum Jülich GmbH Quinacrin als lnhibitor viraler Cysteinproteasen und/oder Serinproteasen
WO2023023651A1 (en) * 2021-08-19 2023-02-23 Arizona Board Of Regents On Behalf Of The University Of Arizona Quinacrine and derivatives thereof for treatment of viral infections
CN115869311A (zh) * 2022-12-30 2023-03-31 湖北工业大学 MefloquineHydrochloride在制备抗腺病毒ADV7药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4181725A (en) * 1977-05-02 1980-01-01 The Regents Of The University Of Michigan Method for alleviating psoriasis
US4496549A (en) * 1983-01-17 1985-01-29 American Cyanamid Company Treatment of malaria with antibiotics
US5153202A (en) * 1988-06-30 1992-10-06 Davis Michael H Method of inhibiting the activity of human immuno deficiency virus (HIV) in vivo
US5376359A (en) * 1992-07-07 1994-12-27 Glaxo, Inc. Method of stabilizing aerosol formulations
US5827681A (en) * 1996-12-20 1998-10-27 University Technology Corporation Rapid detection and drug sensitivity of malaria
US6572858B1 (en) * 1999-04-30 2003-06-03 Apt Pharmaceuticals, Llc Uses for anti-malarial therapeutic agents

Also Published As

Publication number Publication date
CA2466338A1 (en) 2003-05-15
IL161821A0 (en) 2005-11-20
CA2466338C (en) 2010-01-12
AU2002363443B2 (en) 2006-02-16
MXPA04004393A (es) 2005-09-12
WO2003039546A1 (en) 2003-05-15
CN1612735A (zh) 2005-05-04
EP1450803A4 (en) 2008-09-03
EP1450803A1 (en) 2004-09-01
CN1289086C (zh) 2006-12-13
US20040167162A1 (en) 2004-08-26
JP2005512998A (ja) 2005-05-12

Similar Documents

Publication Publication Date Title
HK1075619A1 (en) New uses for anti-malarial therapeutic agents
GB0119152D0 (en) Therapeutic agents
EP1387680A4 (en) AGENTS TH RAPEUTICES D RIV S BENZIMIDAZOLE BASE
IL157642A0 (en) Pyrazolopyrimidines as therapeutic agents
IL157640A0 (en) Pyrazolopyrimidines as therapeutic agents
GB0113841D0 (en) Therapeutic agents
GB0128885D0 (en) Therapeutic agents
GB0120347D0 (en) Therapeutic agents
GB0114867D0 (en) Therapeutic agents
GB0117060D0 (en) Therapeutic agents
GB0108930D0 (en) Therapeutic agents
GB0113839D0 (en) Therapeutic agents
GB0113842D0 (en) Therapeutic agents
GB0111191D0 (en) Therapeutic agents
GB0113843D0 (en) Therapeutic agents
GB0119370D0 (en) Therapeutic agent
GB0119803D0 (en) Therapeutic agents
GB0120345D0 (en) Therapeutic agents
GB0108982D0 (en) Therapeutic agents
GB0119828D0 (en) Therapeutic agents
GB0108973D0 (en) Therapeutic agents
GB0107358D0 (en) Therapeutic agents
GB0108971D0 (en) Therapeutic agents
GB0128157D0 (en) Therapeutic agents
GB0107134D0 (en) Therapeutic agents

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20121112